Primary Clinical Research Areas Investigational Protocols (SUSTAIN & STEP) The clinical profile of Semaglutide is largely defined by the SUSTAIN (diabetes-focused) and STEP (weight-focused) clinical trials
Restaurant Innovation : The dining industry faces perhaps the most direct challenge, as GLP-1 users report dramatically reduced interest in large portions and indulgent meals
That is what this guide solves
This is particularly beneficial for our patients with type 2 diabetes, as it helps in achieving better glycemic control
Additionally, changes in hydration status, diet composition, or existing skin conditions may become more noticeable during active treatment
However, this hasn't been specifically studied in a clinical trial of semaglutide non-responders, so there's no guarantee